Nikrant President, Global Specialty Engineered Materials PolyOne Corporation Page 27 What We Do Concept to Design Specialty Formulations Global Specialty Engineered Materials PolyOne Corporation Page 28 4% Building & 18% Electrical & 16% 5% Transportation 20% 2014 Revenue by Industry Segment 2014 Revenues: $0.6 Billion At a Glance Global Specialty Engineered Materials 44% Europe 33% 19% Latin America PolyOne Corporation Page 29 A Case Study for Transformational Success 1.1% 1.3% 3.4% 5.1% 9.6% 8.0% 8.6% 9.3% 12.1% 2006 2007 2008 2009 2010 2011 2012 2013 2014 Operating Margin $4 $5 $18 $21 $50 $46 $47 $57 $72 2006 2007 2008 2009 2010 2011 2012 2013 2014 Operating Income ($M) Global Specialty Engineered Materials •Globally harmonized specialty strategy and culture •Value proposition and customer centric selling •Differentiation with innovation and service •Expand technology portfolio with select acquisitions PolyOne Corporation Page 30 2006 2014 From Volume… (lbs in millions) 269 286 +6% $42 $163 2006 2014 To Value Gross Margin ($ in millions) +292% Global Specialty Engineered Materials PolyOne Corporation Page 31 Accelerating Growth Innovation Market Growth Geographic Expansion Collaboration Global Specialty Engineered Materials PolyOne Corporation Page 32 Who We Are Growing With Global Specialty Engineered Materials PolyOne Corporation Page 33 Innovation Pipeline Potential Global Specialty Engineered Materials Prototype Frame Opportunity Scale-up & Test Market Build Business Case Commercial Launch Phase 1 Phase 2 Phase 3 Phase 4 Phase 5 3 6 2 3 4 4 2 2 1 3 3 1 3 2 1 Breakthrough Platform Derivative Addressable Market ($ millions) $400 $100 $200 PolyOne Corporation Page 34 Megatrends Aligned with Key End Markets Increasing Energy Efficiency Protecting the Environment Improving Health and Wellness Megatrend End Markets Globalizing and Localizing Health & Wellness Transportation Packaging Consumer Global Specialty Engineered Materials PolyOne Corporation Page 35 >$150M Revenue Potential Advanced Composites Healthcare Key Initiatives Light-weighting >$100M Revenue Potential Global Specialty Engineered Materials PolyOne Corporation Page 36 Platinum Vision 1.1% 8.0% 12.1% 20%+ 2006 2011 2014 2020 Platinum Vision World Class Operating Margin Accelerating Growth Global Specialty Engineered Materials Innovation Market Growth Geographic Expansion Collaboration PolyOne Corporation Page 37 Summary Accelerating growth is #1 priority • Collaboration across PolyOne • Market-driven Innovation • Commercial and Operational Excellence Global Specialty Engineered Materials PolyOne Corporation Page 38 Designed Structures and Solutions PolyOne Corporation Page 39 Custom Engineered 71% Packaging 29% 2%Building & 23% 27% 30% 2014 Revenue by Industry Segment 2014 Revenues: $0.6 Billion At a Glance Designed Structures and Solutions PolyOne Corporation Page 40 Early Progress 1.4% 5.6% 7.3% 2012 2013 2014 Operating Margin $16 $33 $45 2012 2013 2014 Operating Income ($M) • Cultural shift from volume to value • Emphasis on commercial excellence • Mix shift to profitable portfolio of offerings • “Rightsizing” the operational footprint • Deploy Lean Six Sigma Designed Structures and Solutions PolyOne Corporation Page 41 A Lot of Work Remains with Tremendous Upside Potential Guided by our Four Pillar Strategy Specialization Globalization Operational Excellence Commercial Excellence Designed Structures and Solutions Focused on improving: • Quality • On-time Delivery • Operational Efficiency PolyOne Corporation Page 42 Innovating with Cross-Business Unit Technologies Designed Structures and Solutions Specialty Engineered Materials Color and Additives GLS ColorMatrix Geon • Flame retardant solutions • Flexible sound abatement materials • Energy dissipation • Replacement of leaded glass • Foaming technologies • Improved renewable packaging • Next generation barrier packaging • Glass replacement in packaging PolyOne Corporation Page 43 Who We Are Growing With Designed Structures and Solutions PolyOne Corporation Page 44 Security Solutions Aerospace Key Initiatives Architectural Solutions $80M Addressable Market $85M Addressable Market $30M Addressable Market Designed Structures and Solutions PolyOne Corporation Page 45 Platinum Vision 1.4% 5.6% 7.3% 12-14% 2012 2013 2014 2020 Platinum Vision World Class Operating Margin Accelerating Growth Designed Structures and Solutions On-Time Delivery Improving Quality Customer Centric Selling Market Growth Innovation & Collaboration PolyOne Corporation Page 46 Summary Designed Structures and Solutions • Operational improvements to drive quality and service excellence • Continue to invest to optimize and upgrade capabilities to better serve our customers • Execution of four pillar strategy will drive sustained earnings performance • Collaboration will accelerate our success PolyOne Corporation Page 47 Performance Products and Solutions Michael A. S&P 500 -100% 200% 300% 400% 500% 600% POL S&P 500 PolyOne Corporation Page 85 Formula for Success Innovation Market Beating Performance Excellence in Execution PolyOne Corporation Page 86 Track Record of Successful Acquisitions $12 $50 2007 2014 $22 $39 2012 2014 $24 $69 2012 2014 GLS ColorMatrix Spartech OI in $ millions PolyOne Corporation Page 87 Driving Toward Premier Profitability EBIT Margins for top tier companies Victrex 41% 18% Albemarle Eastman 17% Hexcel 17% FMC 16% Ecolab 14% 12% Specialty EBIT Margin – 2014 IFF 19% Celanese 13% PolyOne Corporation Page 88 2006 2014 2020 “Where we were” “Where we are” Platinum Vision Operating Income % Specialty: Global Color, Additives & Inks 1.7% 14.7% 20%+ Global Specialty Engineered Materials 1.1% 12.1% 20%+ Designed Structures & Solutions 1.4%(2012) 7.3% 12 – 14% Performance Products & Solutions 5.5% 7.7% 10 – 12% Distribution 2.6% 6.1% 6.5 – 7.5% Specialty Platform % of Operating Income 6.0% 65% 80%+ ROIC 5.0% 11.3% 15% Adjusted EPS Growth N/A 37% Double Digit Expansion 2020 Platinum Vision PolyOne Corporation Page 89 Platinum Vision: Pathway to Accelerated Growth Organic Sales Growth Margin Expansion Share Repurchases Acquisitions PolyOne Corporation Page 90 2006 2010 2014 2020 Driving Toward a Premium Specialty Multiple 6x 4x Commodity POL 8x Hybrid 10x 14x+ Mid-Tier Specialty Premium Specialty M ul tip le POL POL POL PolyOne Corporation Page 91 The New PolyOne: A Specialty Growth Company Why Invest In PolyOne?

Base Resin ABS PA PBT PC PE PEEK PP PPS Barrel Temperatures °F (°C) Rear Zone 400–475 (200–250) 480–540 (248–282) 480–520 (250–270) 480–570 (250–300) 400–445 (200–230) 660–700 (350–475) 400–440 (200–225) 520–600 (270–300) Center Zone 410–480 (205–253) 490–550 (254–287) 485–525 (251–273) 500–580 (260–305) 410–455 (207–237) 670–710 (357–385) 410–450 (205–230) 550–610 (285–310) Front Zone 420–490 (210–257) 500–560 (260–293) 490–530 (254–276) 515–590 (267–310) 420–465 (213–243) 680–720 (363–400) 420–455 (215–235) 570–620 (300–320) Nozzle 425–500 (215–260) 510–570 (265–298) 490–540 (254–282) 530–600 (275–315) 430–475 (220–250) 700–730 (370–395) 430–460 (220–240) 610–620 (320–325) Melt Temperature 425–515 (215–270) 510–570 (265–298) 490–540 (254–282) 530–615 (275–325) 430–495 (220–260) 700–725 (370–385) 430–475 (220–250) 610–635 (320–335) Mold Temperature 140–200 (60–90) 150–300 (65–148) 140–280 (60–137) 160–240 (70–115) 80–140 (25–60) 300–400 (150–200) 80–140 (25–60) 190–300 (90–150) Drying Parameters 190 (90) 2–4 Hours 0.01%–0.15% 180 (82) 4–5 Hours 0.10%–0.20% 275 (135) 0.02%–0.04% 250 (125) 0.02% 160 (70) 2 Hours 300 (150) 0.10% 160 (70) 2 Hours 280 (135) 2–3 Hours 0.01%–0.20% Nozzle Type General Purpose Nylon or Reverse Taper General Purpose General Purpose General Purpose General Purpose General Purpose General Purpose Injection Velocity1 2–5 in/sec; 50–127 mm/sec Injection Pressure 1,000–2,000 psi; 7–14 Mpa Back Pressure 50–100 psi; 0.3–0.7 Mpa Screw Speed 25–75 RPM Cushion 0.125–0.250 in; 3–6 mm Screw Compression Ratio2 2.0:1–2.5:1 Comments 1.

We also conduct 360 assessments to help associates assess their individual development and progression based on feedback from key stakeholders. Versaflex™ HC Thermoplastic Elastomers are formulated to meet demanding healthcare device and application challenges without phthalate plasticizers. Versaflex™ PF Tack Layer for Surface Protective Films lower VOC emissions during manufacturing and eliminate secondary coating and drying operations.

Ltd（ 韩国 ） 3 Fl, Sungbo B/D, 718 - 24 Yeoksam-Dong, Kangnam-Ku 邮编：135 080 电话：+82 2 562 1501 mjyu@dictkr.com Muybien Enterprise Co., Ltd. （ 台湾） 慕名企业有限公司 台湾台北市林森北路380号10楼之2 电话：+886 2 2561 4277 service@muybien.com.tw Nisshin & Co., Ltd. （ 日本 ） 日本东京中央日本桥本石町3-3-5日本 桥Toku大厦5楼 邮编：1103-0021 电话：+81 3 3271 6636 yu.kiyohara@e-nisshin.com 经销商 Nishigandha Polymers Pvt.

Use of Non-GAAP Measures Page 3 PolyOne Commodity to Specialty Transformation Page 4 • Continue specialty transformation • Targeting $2.50 Adjusted EPS by 2015, nearly double 2013 EPS • Drive double digit operating income and adjusted EPS growth • 17 consecutive quarters of double- digit adjusted EPS growth • Shift to faster growing, high margin, less cyclical end markets • Key acquisitions propel current and future growth, as well as margin expansion • Established aggressive 2015 targets • Steve Newlin Appointed, Chairman, President and CEO • New leadership team appointed • Implementation of four pillar strategy • Focus on value based selling, investment in commercial resources and innovation to drive transformation • Volume driven, commodity producer • Heavily tied to cyclical end markets • Performance largely dependent on non- controlling joint ventures 2000-2005 2006 - 2009 2010 – 2013 2014 and beyond -150.00% -50.00% 50.00% 150.00% 250.00% 350.00% PolyOne S&P 500 Russell 2000 Dow Jones Chemical All time high of $38.38 March 7th, 2014 • 17 consecutive quarters of double digit EPS growth • 49% CAGR adjusted EPS expansion 2006-2013 • 2013 stock price increased 73% versus 30% growth in the S&P • More than seven fold increase in market cap: $0.5b $3.6b Strategy and Execution Drive Results Page 5 Appliance 4% Building & Construction 13% Wire & Cable 9% Electrical & Electronics 5% Consumer 10%Packaging 16% Industrial 12% HealthCare 11% Transportation 18% Misc. 2% United States 66% Europe 14% Canada 7% Asia 6% Latin America 7% PP&S Specialty 53% Distribution 27% 0.12 0.27 0.21 0.13 0.68 0.82 1.00 1.31 2.50 $0.00 $0.25 $0.50 $0.75 $1.00 $1.25 $1.50 $1.75 $2.00 $2.25 $2.50 2006 2007 2008 2009 2010 2011 2012 2013 2015 Target Ad ju st ed E ar ni ng s P er S ha re 2013 Revenues: $3.8 Billion End Markets 2013 Revenues: $3.8 Billion EPS Page 6 PolyOne At A Glance Old PolyOne Transformation *Operating Income excludes corporate charges and special items 2% 34% 43% 62% 65- 75% 0% 20% 40% 60% 80% 100% 2005 2008 2010 2013 2015 % o f O pe ra tin g In co m e* JV's Performance Products & Solutions Distribution Specialty Specialty OI $5M $46M $87M $195M Target Mix Shift Highlights Specialty Transformation 2015 Target Page 7 2006 2013 2015 “Where we were” “Where we are” Target 1) Operating Income % Specialty: Global Color, Additives & Inks 1.7% 12.2% 12 – 16% Global Specialty Engineered Materials 1.1% 9.3% 12 – 16% Designed Structures & Solutions -- 5.6% 8 – 10% Performance Products & Solutions 5.4% 7.2% 9 – 12% Distribution 2.6% 5.9% 6 – 7.5% 2) Specialty Platform % of Operating Income 6.0% 62% 65 – 75% 3) ROIC* (after-tax) 5.0% 9.1% 15% 4) Adjusted EPS Growth N/A 31% Double Digit Expansion Proof of Performance & 2015 Goals *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period Page 8 Bridge To $2.50 Adjusted EPS By 2015 2015 EPS: $2.50 2013 EPS: $1.31 Mid single digit revenue CAGR Page 9 Mergers & Acquisitions Spartech accretion Incremental share buybacks Ongoing LSS Programs (50-100 bps/yr) Accelerated Innovation & Mix Improvement Innovation Drives Earnings Growth $20.3 $52.3 2006 2013 Research & Development Spending ($ millions) Specialty Platform Vitality Index Progression* *Percentage of Specialty Platform revenue from products introduced in last five years Page 10 14.3% 30.7% 2006 2013 Specialty Platform Gross Margin % 19.5% 43.0% 2006 2013 Healthcare Consumer Packaging and Additive Technology Transportation Page 11 Unique and Innovative Solutions that Help Customers Win https://www.dropbox.com/sh/dwe4t8aacvhb8ui/uD3p_bdglP/Presentation revise pics/GLS Beverage can closure XO 2.jpg https://www.dropbox.com/sh/dwe4t8aacvhb8ui/-YgkycKypw/Anti-Counterfeiting release & images/GN1979.JPG Net Debt / EBITDA* = 1.8x $48 $317 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Significant Debt Maturities As of December 31, 2013 ($ millions) Page 12 Coupon Rates: 7.500% 7.375% 5.250% Debt Maturities & Pension Funding – 12/31/13 *TTM 12/31/2013 ** includes US-qualified plans only 60% 100% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2008 2013 Pension Funding** As of December 31, 2013 Free Cash Flow and Strong Balance Sheet Fund Investment •Targets that expand our: • Specialty offerings •End market presence •Geographic footprint •Operating Margin • Synergy opportunities •Adjacent material solutions •Expanding our sales, marketing, and technical capabilities • Investing in operational and LSS initiatives (including synergy capture) •Manufacturing alignment Organic Growth Share Repurchases Dividends Acquisitions Page 13 $0.16 $0.20 $0.24 $0.32 $0.00 $0.10 $0.20 $0.30 $0.40 2011 2012 2013 2014 Annual Dividend • Repurchased ~5 million shares in 2013 • 15 million shares are available for repurchase under the current authorization The New PolyOne: A Specialty Growth Company 2015 Target: $2.50 Adjusted EPS Why Invest In PolyOne?

Healthcare TPEs: Versaflex™ HC

Morgan • New Senior Secured Term Loan B and new Senior Unsecured Notes • Potential proceeds from sale of Distribution business modeled to pay off 5.25% senior notes due 2023 and Term Loan • Acquisition aligned with Avient’s track record of disciplined capital allocation policy • Existing dividend policy maintained, focus on deleveraging in the near term (1) Pro forma for the acquisition of Dyneema® and potential divestiture of Distribution, including repayment of senior notes due 2023 and Term Loan Cash and Cash Equivalents 595$ Senior Secured Term Loan due 2026 605$ New Senior Secured Term Loan B 500 Total Senior Secured Debt 1,105$ Senior Unsecured Notes due 2025 650$ New Senior Unsecured Notes 740 Total Senior Unsecured Debt 1,390$ Total Debt 2,495$ Net Debt 1,900$ 2022 Pro forma Adjusted EBITDA 660$ Net Debt / Adjusted EBITDA 2.9x Pro Forma Capitalization (2022 estimates, all figures in $M) TWO-YEAR LEVERAGE GOAL 33 3.5x 2.7x 1.7x 2.9x 2.5x 2.2x 2019PF 2020PF 2022E 2022PF 2023E 2024E Dyneema® AcquisitionClariant Color Acquisition (1) Pro forma for the acquisition of the Clariant Color business (2) Pro forma for the acquisition of Dyneema® and potential divestiture of Distribution, including repayment of senior notes due 2023 and Term Loan (1) (1) (2) 34 PRO FORMA MODELING 2022E Pro Forma Pro Forma ($M) w/ Dyneema w/Sale Revenue 5,100$ 415$ 5,515$ (1,775)$ 3,740$ Adjusted EBITDA 635 130 765 (105) 660 EBITDA % 12% 31% 14% 6% 18% Pro Forma EPS (Adjusted) 3.50$ 0.00$ 3.50$ (0.56)$ 2.94$ Pro Forma EPS (excl. amortization) 3.96$ 0.35$ 4.31$ (0.56)$ 3.75$ Leverage (12/31/2022E) Net Debt / Adjusted EBITDA 1.7x 3.5x 2.9x Avient Dyneema Distribution® ® OUR SPECIALTY JOURNEY ACQUISITION HISTORY 36 Commercial Resources(1) Operating Margins 259 360 $40 $122 Established Acquisitions (> 7 years) + 39% + 210% + 1200 bps (1) Commercial Resources include associate headcount in R&D / Technical, Marketing and Sales CLARIANT COLOR ACQUISITION 37 $133 $205 2019PF 2021 37 Clariant Color EBITDA Growth Purchase Price Multiple 10.8x 7.0x 6.1x 2019PF 2021 2021 w/ Full Synergies • Acquisition of Clariant Color business significantly expanded presence in healthcare, packaging and consumer end markets • Strength of portfolio – double-digit annual EBITDA growth since acquisition • $54 million of synergies realized in 2021 • Acquisition completed on July 1, 2020 for $1.45 billion.

Operating Income $3,783 $4,100 (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition Previous Guidance Current Guidance $3,783 $4,300 $308 $360 $308 $410 $1.93 $2.40 $1.93 $2.80 (1) (1)(1) (1)(1) (1) $442 $457 $560 $1.74 $1.93 $2.80 FULL YEAR 2019 – 2021 ORGANIC GROWTH 23 Sales Adjusted EBITDA $3,981 $3,783 $4,300 + 8% (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition (1)(1) + 27% + 61% 24 BALANCE SHEET • Deleveraging to 1.9x net debt to adjusted EBITDA by the end of 2021 • Driven by record adjusted EBITDA performance and strong free cash flow generation from asset light business • Future cash deployment: M&A, opportunistic share repurchases and balance sheet / continued leverage reduction 3.5x 2.7x 1.9x Net Debt / Adjusted EBITDA ($ in millions) 2021E Adjusted EBITDA 560$ Free Cash Flow 275$ Total Debt 1,860 Less: Cash (800) Net Debt 1,060$ 2021E Net Debt / Adjusted EBITDA 1.9x (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition PEER COMPARISONS 25 As a specialty formulator, we don’t require significant capital investment, as compared to the base resin raw material suppliers we purchase from.

This segment includes GLS Corporation (GLS), which we acquired in 2008. We believe GLS offers the broadest range of soft-touch thermoplastic elastomers in the industry. The fair value of the GLS trade name is calculated using a “relief from royalty payments” methodology.

Operating Income $3,783 $4,100 (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition Previous Guidance Current Guidance $3,783 $4,300 $308 $360 $308 $410 $1.93 $2.40 $1.93 $2.80 (1) (1)(1) (1)(1) (1) $442 $457 $560 $1.74 $1.93 $2.80 FULL YEAR 2019 – 2021 ORGANIC GROWTH 23 Sales Adjusted EBITDA $3,981 $3,783 $4,300 + 8% (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition (1)(1) + 27% + 61% 24 BALANCE SHEET • Deleveraging to 1.9x net debt to adjusted EBITDA by the end of 2021 • Driven by record adjusted EBITDA performance and strong free cash flow generation from asset light business • Future cash deployment: M&A, opportunistic share repurchases and balance sheet / continued leverage reduction 3.5x 2.7x 1.9x Net Debt / Adjusted EBITDA ($ in millions) 2021E Adjusted EBITDA 560$ Free Cash Flow 275$ Total Debt 1,860 Less: Cash (800) Net Debt 1,060$ 2021E Net Debt / Adjusted EBITDA 1.9x (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition PEER COMPARISONS 25 As a specialty formulator, we don’t require significant capital investment, as compared to the base resin raw material suppliers we purchase from.